等待開盤 09-17 09:30:00 美东时间
-0.200
-0.53%
今日重点评级关注:Ascendiant Capital:维持SurgePays"买入"评级,目标价从3.5美元升至3.75美元;HC Wainwright & Co.:维持Spero Therapeutics"买入"评级,目标价从5美元升至6美元
09-15 15:30
Evercore ISI Group analyst Michael Griffin maintains Phillips Edison & Co (NASDAQ:PECO) with a Outperform and lowers the price target from $47 to $46.
09-14 21:37
This week's dividend activity included increased payouts from Phillips Edison (PECO) and VICI Properties (VICI) as well as declarations from Broadcom (AVGO) and Salesforce (CRM). Additionally, looking...
09-04 21:07
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07
Phillips Edison (PECO) declares $0.115/share monthly dividend, 6.2% increase from prior dividend of $0.108. Forward yield 3.55% Payable Oct. 1; for shareholders of record Sept. 15; ex-div Sept. 15. Pa...
09-02 04:10
Wells Fargo analyst James Feldman maintains Phillips Edison & Co (NASDAQ:PECO) with a Equal-Weight and lowers the price target from $47 to $43.
09-01 22:48
Phillips Edison & Company, Inc. (PECO) announced a 6.2% increase in its monthly dividend, effective October 1, 2026. The new rate is $0.115 per share, annualizing to $1.38, up from $1.30. This marks PECO's sixth consecutive annual dividend increase and third over 5%. Jeff Edison, CEO, highlighted strong cash flows and commitment to shareholder value. PECO owns and operates 330 shopping centers across the U.S., anchored by major grocers.
09-01 20:05
今日重点评级关注:Canaccord Genuity:维持Cardiol Therapeutics"买入"评级,目标价从8美元升至10美元;B. Riley证券:维持Macrogenics"买入"评级,目标价从9美元升至11美元
08-18 11:39
Barclays analyst Richard Hightower maintains Phillips Edison & Co (NASDAQ:PECO) with a Equal-Weight and raises the price target from $45 to $46.
08-17 21:59
Phillips Edison (PECO) declares $0.1083/share monthly dividend, in line with previous. Forward yield 3.12% Payable Sept. 1; for shareholders of record Aug. 17; ex-div Aug. 17. See PECO Dividend Scorec...
08-06 05:58